Application for quotation of securities - TLX

Sep 25, 2026 at 1:17 AM EDT · Issued by Telix Pharmaceuticals Limited via ASX

Filed with ASX · Sep 25, 2026 at 1:17 AM EDT

On 6ix: 6ix.com/news/application-for-quotation-of-securities-tlx-2

Appendix 2A - Application for quotation of securitiesAppendix 2A - Application for quotation of securities1 / 6Announcement SummaryEntity nameTELIX PHARMACEUTICALS LIMITEDAnnouncement TypeNew announcementDate of this announcementFriday September 25, 2026The +securities to be quoted are:Please refer...

View Attachment

6ix hasn’t read this filing yet.

Telix Pharmaceuticals Limited on 6ix

Earlier from Telix Pharmaceuticals

Grant of waivers of Listing Rule 7.3.4Sep 21
Telix and ITM Join Forces to Create a Radiopharmaceutical PowerhouseSep 20
Telix and ITM Join Forces to Create Radiopharma PowerhouseSep 20
FDA Approves Telix's Brain Cancer Imaging Drug PixclaraSep 14
FDA Approves Telix Brain Cancer Imaging Drug PixclaraSep 13

Later from Telix Pharmaceuticals

Appendix 3Y Change in Director Interest-D GillSep 25
Change in substantial holdingSep 25
FDA Fast Track for BiPASS Pre Biopsy Prostate ImagingSep 29
Telix Granted FDA Fast Track Designation for BiPASS Pre-Biopsy Prostate Cancer ImagingSep 29
Notification regarding unquoted securities - TLXOct 4

All Telix Pharmaceuticals news releases

Follow Telix Pharmaceuticals into a list and get an email when it puts out news.

Follow Telix Pharmaceuticals